Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108101785A reveals iridium catalysis for chiral beta-hydroxy esters. Offers high ee and mild conditions for pharma supply chains. Enables cost reduction in pharmaceutical intermediates manufacturing.
Patent CN102372729A details a novel, high-yield synthesis of Cefoperazone Sodium using recyclable dimethyl carbonate, offering significant cost and purity advantages for pharmaceutical manufacturers.
Patent CN104311597A enables toxic solvent-free recrystallization and reduced inorganic salt residues for scalable antibiotic prodrug manufacturing.
Novel asymmetric reduction route for Baloxavir Marboxil isomer. Eliminates chiral resolution, reduces cost, ensures supply chain stability for pharmaceutical manufacturing.
Novel patent CN105541724A details a mild method for Methimazole. Achieves high purity and yield. Offers cost reduction in API manufacturing and supply chain reliability.
Patent CN104592337A reveals improved phosphorylation method ensuring high purity and simplified processing for cost reduction in API manufacturing supply chains.
Discover the novel one-pot synthesis of Panipenem via patent CN101885727A. Achieve high purity intermediates and significant cost reduction in pharmaceutical manufacturing.
Patent CN100404686C details enzymatic resolution of C-24 hydroxy vitamin D isomers, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN108059590A details a mild lithiation method for high-purity 3-trifluoromethoxy-4-chlorobenzaldehyde. This process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101007816A details a chromatography-free route for Biapenem, offering significant cost and scalability advantages for pharmaceutical manufacturers.
Patent CN115976130A reveals a novel enzymatic route for Rimegepant intermediate VI, achieving 90.1% yield and superior impurity control for reliable pharmaceutical supply chains.
Patent CN102432496B reveals an acidic purification method for Carbidopa, achieving high purity and yield. Ideal for reliable pharmaceutical intermediates supplier partnerships.
Patent CN111349677B details high-purity steroid intermediate synthesis using recombinant enzymes for cost-effective pharmaceutical manufacturing supply chains and reduced environmental impact.
Novel boric acid-catalyzed route for 4,4-dichlorodiphenyl sulfone. Low temperature, high purity, reduced isomers. Ideal for pharma and polymer industries.
Patent CN103435523B reveals a cost-effective route for Sitafloxacin intermediates ensuring supply chain stability and high purity for global pharmaceutical manufacturing partners.
Patent CN114213298A reveals a metal-free route for thiosulfonates using air and NCS, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel patent CN106188047B details high-yield synthesis of moxifloxacin intermediate. Offers cost reduction and supply chain reliability for pharmaceutical manufacturers seeking scalable solutions.
Patent CN102643267B details efficient synthesis reducing TNF-alpha. Offers scalable routes for high-purity pharmaceutical intermediates with supply chain stability.
Patent CN115677599A details a green synthesis route for this key veterinary API intermediate, offering higher purity and reduced environmental impact compared to traditional pyridine-based methods.
Patent CN112094182A reveals a green molecular sieve catalyzed route for benzocyclohexanones, offering cost reduction and supply chain reliability for API manufacturing.